600812.SS
600812.SS
CNE000000D16
NORTH CHINA PHARMACEUTICAL CO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 9.241.652.954 9.869.575.819
6.4%
Cost of Revenue 6.376.291.488 6.714.658.593
5.0%
Gross Profit 2.865.361.466 3.154.917.226
9.2%
2.199.803.620 2.425.020.792
9.3%
Operating Income 665.557.846 729.896.434
8.8%
Pretax Income 357.408.948 309.832.513
15.4%
Net Income Common Stockholders 183.056.161 126.992.370
44.1%
-- --
--
-- --
--
ende